WHEN: 25, 26 March 2026
WHERE: DAY 1: Corporate Stage, Exhibition Hall 1. DAY 2: Boardrooms 1, 2 & 3 – Sandton Convention Centre
| Day | Time | Topic | Synopsis | Speaker |
|---|---|---|---|---|
| Day 1 – 25 March 2026 | 13:30 | Provide Protection for Your COPD Patients | – | Prof Guy Richards |
| Day 2 – 26 March 2026 | 09:15-09:30 | Arrival – Breakfast in foyer | Welcome and breakfast | – |
| 09:30-10:00 | COPD Pharmacist’s Perspective: Reframing the impact of pharmacy in COPD Care | This session reframes the role of community pharmacy in COPD care by linking disease burden and the patient journey to practical, pharmacy-led actions. Device education (MDI vs DPI), treatment principles, contraindications, and cautions are covered. Attendees gain actionable strategies to improve COPD outcomes. | Prof S. Steyn | |
| 10:00-10:30 | CKD Pharmacist’s Perspective: CKD at the pharmacy counter: Risks & Actions | Pharmacists learn to provide safety-focused counselling for CKD patients, identify nephrotoxic agents, advise on dosing, hydration, sodium limits, and coordinate with prescribers. Quick-reference tools and dietary guidance included. | Prof S. Steyn | |
| 10:30-11:00 | BREAK | – | – | |
| 11:00-11:30 | COPD General Practitioner’s Perspective: COPD: More than just lung disease | Review of COPD disease burden, exacerbation impact, GOLD and local guidelines, dual vs triple therapy, ICS use, and personalized primary care strategies to reduce exacerbations and improve outcomes. | Dr Kuven Naidu | |
| 11:30-12:00 | CKD General Practitioner’s Perspective: From albuminuria to action, CKD management | Early CKD detection, UACR/eGFR interpretation, stage CKD, escalation thresholds, follow-up timing, and case studies. Focus on reducing progression and enhancing cardio-renal outcomes. | Dr Kuven Naidu | |
| 12:00-12:10 | Q&A & QR Code feedback | Interactive session for attendees to ask questions and provide feedback. | – | |
| 12:10 | Close | End of session | – |
